Transcranial ultrasound and olfaction in REM sleep behavior disorder: Testing predictors of Parkinson's disease

Sleep Medicine

Volumn 11, Issue 4, 2010, Pages 339-340

  Postuma, R B ^a,b   Montplaisir, J ^b,c  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ANOSMIA; DIFFUSE LEWY BODY DISEASE; DOPPLER ECHOGRAPHY; EDITORIAL; HUMAN; HYPOSMIA; NERVE DEGENERATION; PARASOMNIA; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE;

OLFACTION DISORDERS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; REM SLEEP BEHAVIOR DISORDER; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 77949918123     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2009.12.004     Document Type: Editorial

References (6)

1. Boeve B.F., Silber M.H., Saper C.B., et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007, 130:2770-2788.
2. Postuma R.B., Gagnon J.F., Vendette M., Montplaisir J. Markers of neurodegeneration in idiopathic REM sleep behavior disorder and Parkinson disease. Brain 2009, 132:3298-3307.
3. Ross G.W., Petrovitch H., Abbott R.D., et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008, 63:167-173.
4. Gaenslen A., Unmuth B., Godau J., et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 2008, 7:417-424.
5. Iwanami M., Miyamoto T., Miyamoto M., et al. Relevance of substantia nigra hyperechogenecity and reduced odor identification in idiopathic REM sleep behavior disorder. Sleep Med 2010, 11:361-365.
6. Stockner H., Iranzo A., Seppi K., et al. Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder. Mov Disord 2009, 24:1906-1909.